Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

"This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at The Foundation for ...

The Trump administration’s budget proposal sends a dangerous message: that the lives and health of people living with HIV are ...

The new rules mean that people like Covin won’t have to go to the trouble of finding a doctor breaking guidelines to be supportive of women breastfeeding while living with HIV; instead ...

Getty Images Guidelines for HIV-positive mothers who wish to breastfeed have been updated with new recommendations. HIV-positive mothers with undetectable viral load can now safely breastfeed ...